We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-23.25%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$358M
AUM Growth
-$182M
(-34%)
Cap. Flow
-$93.9M
Cap. Flow
% of AUM
-26.23%
Top 10 Holdings %
Top 10 Hldgs %
31.98%
Holding
756
New
76
Increased
136
Reduced
196
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Poland ETF
EPOL
|
+$9.75M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$8.54M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$7.11M |
| 4 |
iShares MSCI Turkey ETF
TUR
|
+$6.88M |
| 5 |
VanEck Oil Services ETF
OIH
|
+$6.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$24.1M |
| 2 |
Ferrari
RACE
|
+$13.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$10.2M |
| 4 |
iShares MSCI Malaysia ETF
EWM
|
+$9.43M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$8.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.28% |
| 2 | Technology | 9.96% |
| 3 | Financials | 8.31% |
| 4 | Consumer Discretionary | 6.97% |
| 5 | Communication Services | 4.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MYOK
301
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $83.9K | 0.02% |
+1,790
| New | +$115K |
|
302
Lumen
LUMN
$6.37B
| $82K | 0.02% |
8,666
-263,963
| -97% | -$3.3M |
|
303
IAMGOLD
IAG
$8.5B
| $80.5K | 0.02% |
35,305
-3,923
| -10% | -$11.4K |
|
304
Nucor
NUE
$56.1B
| $80.1K | 0.02% |
2,224
-63,994
| -97% | -$2.84M |
|
305
Phathom Pharmaceuticals
PHAT
$948M
| $80.1K | 0.02% |
+3,102
| New | +$104K |
|
306
General Motors
GM
$77B
| $79.5K | 0.02% |
3,827
+1,300
| +51% | +$39.7K |
|
307
Merit Medical Systems
MMSI
$4.56B
| $78.2K | 0.02% |
+2,504
| New | +$89.2K |
|
308
Newmont
NEM
$98.4B
| $77.9K | 0.02% |
1,720
-6,053
| -78% | -$273K |
|
309
SSR Mining
SSRM
$5.51B
| $77.4K | 0.02% |
6,848
| – | – |
|
310
Tilray
TLRY
$496M
| $76.9K | 0.02% |
1,116
-250
| -18% | -$34.9K |
|
311
AGNC Investment
AGNC
$12.4B
| $76.7K | 0.02% |
7,252
| – | – |
|
312
Axsome Therapeutics
AXSM
$12.3B
| $76.5K | 0.02% |
+1,300
| New | +$106K |
|
313
Vanguard Energy ETF
VDE
$9.92B
| $76.4K | 0.02% |
+2,000
| New | +$127K |
|
|
FSTX
314
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $75.9K | 0.02% |
+20,400
| New | +$106K |
|
315
PTC Therapeutics
PTCT
$6.34B
| $75.4K | 0.02% |
1,691
-251
| -13% | -$12.6K |
|
|
ATRS
316
DELISTED
Antares Pharma, Inc.
ATRS
| $75.1K | 0.02% |
+31,811
| New | +$108K |
|
317
Abbott
ABT
$184B
| $75K | 0.02% |
950
-192
| -17% | -$16K |
|
|
TCDA
318
DELISTED
Tricida, Inc. Common Stock
TCDA
| $74.4K | 0.02% |
+3,380
| New | +$109K |
|
319
Becton Dickinson
BDX
$44.1B
| $71.7K | 0.02% |
320
| – | – |
|
320
Coca-Cola Europacific Partners
CCEP
$47.8B
| $71.4K | 0.02% |
1,903
-13,895
| -88% | -$675K |
|
321
Encompass Health
EHC
$11.4B
| $71.3K | 0.02% |
1,399
-202
| -13% | -$11.6K |
|
322
Chemed
CHE
$6.81B
| $71K | 0.02% |
164
-26
| -14% | -$11.6K |
|
|
BCEL
323
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $70.7K | 0.02% |
+4,270
| New | +$77.4K |
|
324
Royal Gold
RGLD
$17.1B
| $69.7K | 0.02% |
795
+525
| +194% | +$54.2K |
|
325
Starbucks
SBUX
$119B
| $68.7K | 0.02% |
1,045
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q1 2020 Portfolio in Review
As of Q1 2020, Exane Derivatives held 756 positions worth $358M, down 34% from $540M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Exane Derivatives withdrew a net $93.9M in Q1 2020, closing 54 positions and reducing 196 holdings. Its most notable exit was Ferrari, an estimated $13.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 5.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Exane Derivatives opened a new position in VanEck Oil Services ETF worth $2.8M.
- Exane Derivatives's largest Q1 2020 buy was VanEck Oil Services ETF: 34,775 shares worth $2.8M.
- Exane Derivatives added most to iShares MSCI Poland ETF in Q1 2020, an estimated $9.75M increase.
- Exane Derivatives's biggest Q1 2020 reduction was UBS Group, cutting an estimated $24.1M.
- Exane Derivatives fully exited Ferrari in Q1 2020, selling an estimated $13.3M.
- Exane Derivatives's ten largest holdings make up 32% of its $358M portfolio in Q1 2020.
- Exane Derivatives opened 76 new positions and closed 54 in Q1 2020.
- Exane Derivatives's portfolio value fell 34% quarter-over-quarter to $358M.
Based on Exane Derivatives's 13F filing for Q1 2020, filed 17 Apr 2020.